Sources | Names Used |
---|---|
CTRPv2 | Compound 1541A |
PharmacoGx | Compound 1541A |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | LDHC | CTRPv2 | pan-cancer | AAC | -0.076 | 0.05 |
mRNA | GNG3 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.05 |
mRNA | VAMP3 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.05 |
mRNA | CNTN4 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.05 |
mRNA | RTN4 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.05 |
mRNA | ST20-MTHFS | CTRPv2 | pan-cancer | AAC | -0.077 | 0.05 |
mRNA | EXOC8 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.05 |
mRNA | TMEM39B | CTRPv2 | pan-cancer | AAC | 0.082 | 0.05 |
mRNA | LAIR2 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.05 |
mRNA | RPS6KA5 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.05 |